|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 31/485 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/22 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 47/18 | (2017.01) |
| (11) | Number of the document | 2521536 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11703294.6 |
| Date of filing the European patent application | 2011-01-07 | |
| (97) | Date of publication of the European application | 2012-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-01 |
| (46) | Date of publication of the claims translation | 2018-10-10 |
| (86) | Number | PCT/US2011/020457 |
| Date | 2011-01-07 |
| (87) | Number | WO 2011/085158 |
| Date | 2011-07-14 |
| (30) | Number | Date | Country code |
| 293227 P | 2010-01-08 | US | |
| 986223 | 2011-01-07 | US |
| (72) |
DIX, Daniel, B., US
GRAHAM, Kenneth, S., US
KAMEN, Douglas, E., US
WALSH, Scott, M., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Stabilizuotos kompozicijos, turinčios savo sudėtyje antikūnus prieš interleukino-6 receptorių (IL-6R) |
| STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2024-12-18 | 15 | 289.00 EUR |
| 2026-01-07 |